# Project VerioVue Enhancements - Neonate Study

> **NCT06052371** · — · TERMINATED · sponsor: **LifeScan Scotland Ltd** · enrollment: 99 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** VerioVue (Enhancements) blood glucose monitoring system

## Key facts

- **NCT ID:** NCT06052371
- **Lead sponsor:** LifeScan Scotland Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-16
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** This study was terminated for business reasons.
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06052371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06052371, "Project VerioVue Enhancements - Neonate Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06052371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*